<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00197392</url>
  </required_header>
  <id_info>
    <org_study_id>BAC-IN02-002</org_study_id>
    <nct_id>NCT00197392</nct_id>
  </id_info>
  <brief_title>Comparative Infection Rates for the Codman BACTISEAL TM External Ventricular Drainage (EVD) System</brief_title>
  <official_title>Establishment of Baseline and Comparative Infection Rates for the Codman BACTISEAL TM External Ventricular Drainage (EVD) System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Codman &amp; Shurtleff</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Codman &amp; Shurtleff</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this non-significant risk study is to establish initial baseline infection
      rates for the Codman BACTISEAL External Ventricular Drainage (B-EVD) System (Antibiotic
      impregnated catheter) and to compare relative rates of ventriculostomy-related infection
      between Subjects with BACTISEAL or conventional EVD catheters in a prospective, randomized
      open label study
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      External ventricular drainage catheters are widely used in the management of Subjects with
      elevated intra-cranial pressure (ICP) secondary to acute hydrocephalus due to sub-arachnoid
      hemorrhage, intra-cerebral hemorrhage, intra-ventricular hemorrhage and other causes that
      obstruct the cerebrospinal fluid (CSF) circulation. However, this mode of treatment could be
      compromised by the increased risk of catheter related CSF infection.

      B-EVD is manufactured using a patented process to impregnate silicone catheters with two
      antibiotics, rifampin and clindamycin. These antibiotics are impregnated throughout the
      silicone matrix. After implantation, slow release of both antibiotics at the extra- and
      intra-luminal catheter surfaces minimizes the likelihood of bacterial colonization. The B-EVD
      Catheter System has, to date, been well accepted by domestic and European customers.
      Currently there exists sound scientific rationale and promising bench-top in vitro data to
      anticipate low levels of ventriculostomy-related infection in Subjects using this system.
      Published BACTISEAL shunt data and direct feedback from U.S. market experience also support
      this notion. There are no published clinical studies reporting infection rates with the use
      of the B-EVD System, making all statements regarding its propensity to minimize clinical risk
      for catheter-related infection mere speculation and anecdotal. Therefore, Codman proposes to
      undertake a controlled clinical evaluation of this product to demonstrate its influence on
      EVD catheter-related infections, using a conventional EVD catheter as a standard of
      reference.

      Immediately following successful screening, the Subject will be randomized to test or control
      group and will have the appropriate EVD system implanted. The Treatment Phase will cover the
      duration of the implanted EVD system. Subjects will be monitored for 2 weeks post-explant.

      This study is expected to enroll 600 evaluable implanted Subjects at up to 15 Investigational
      Sites in US, Europe and Asia-Pacific
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2004</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Infections</measure>
    <time_frame>Duration of implanted EVD system to 2 week post implant</time_frame>
    <description>The number of infections for the Codman Bactiseal EVD Catheter and the number of infections for a Standard EVD Catheter (ventriculostomy-related infections).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Days to Proven Infection</measure>
    <time_frame>Implantation of EVD System to explant of EVD catheter, an average of ten days</time_frame>
    <description>Number of days to proven infection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Class of Bacterial Agent Causing Proven Infection</measure>
    <time_frame>Implantation of subject to post implant</time_frame>
    <description>Type of bacterial agent related to proven infection in Bactiseal EVD and Standard EVD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraluminal Colonization on Catheters</measure>
    <time_frame>Implant of subjects to post implant</time_frame>
    <description>Number of catheters with Bacterial colonization verified using fluorescence.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device Related Adverse Events</measure>
    <time_frame>Implanted subjects to time of explant</time_frame>
    <description>Number of Device Related Adverse Events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Days With Indwelling Catheter</measure>
    <time_frame>Implant of subjects to day of explant</time_frame>
    <description>Days catheter was implanted in subjects</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average Subject Age</measure>
    <time_frame>Implant to subject</time_frame>
    <description>The average subject age</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnosis Requiring EVD Implantation</measure>
    <time_frame>Implantation of EVD system</time_frame>
    <description>Primary diagnosis for implantation of EVD system</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-infectious Catheter Failure in the MITT Population</measure>
    <time_frame>Implant of subject to explant</time_frame>
    <description>Reasons for non-infectious catheter malfunctions in the Modified intent to treat population.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time Point of Introduction of Systemic Antibiotic Therapy</measure>
    <time_frame>Within 48 hours of implant of subjects to explant</time_frame>
    <description>Time points of then patients received systemic antibiotic therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Locations for EVD Catheter Placement</measure>
    <time_frame>Implantation of subject</time_frame>
    <description>Number of subjects in each analysis population where the EVD catheter placement occurred; either in the Intensive Care Unit (ICU)or the Operating Room (OR).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Catheter Tunneling Into the Brain</measure>
    <time_frame>Implant of subject</time_frame>
    <description>Length of tunneling of EVD catheter in the brain for each analysis population.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Catheter Insertion Attempts</measure>
    <time_frame>Implantation of subject</time_frame>
    <description>Number of insertions needed to place catheter</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">434</enrollment>
  <condition>Intraventricular Hemorrhage</condition>
  <condition>Subarachnoid Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Bactiseal TM EVD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bactiseal External Ventricular Drainage System.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard EVD Catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard External Ventricular Device system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bactiseal TM EVD</intervention_name>
    <description>Standard of care implantation of external ventricular drainage catheter</description>
    <arm_group_label>Bactiseal TM EVD</arm_group_label>
    <other_name>EVD,Bactiseal, standard</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard EVD Catheter</intervention_name>
    <description>Standard of care EVD system other than Bactiseal.</description>
    <arm_group_label>Standard EVD Catheter</arm_group_label>
    <other_name>EVD, ventricular catheters</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The Subject is 18 years or older.

          -  The Subject (family member/legal representative) has given written Informed Consent
             prior to enrollment into this trial OR, where the Subject is unable to consent and no
             relative/legal representative is available to offer consent, appropriate legal and
             ethical practices are employed and thoroughly documented according to the laws and
             policies of the respective country and institution.

          -  The Subject (family member/legal representative) is willing to participate in this
             trial for the duration of the implanted EVD system and is willing to comply with the
             protocol requirements.

        Exclusion Criteria:

          -  Within the preceding 30 days, the Subject has enrolled or participated in another
             trial utilizing an anti-microbial drug or medical device implanted in or directly
             influencing the CNS and/or spinal cord.

          -  The Subject is pregnant or lactating.

          -  The Subject has a suspected or documented allergy to the materials of the EVD system,
             including silicone, rifampin and clindamycin.

          -  The Subject has a positive CSF culture prior to EVD implant.

          -  The Subject is immunocompromised.

          -  The Subject requires more than one ventricular catheter concurrently.

          -  The Subject has had an EVD catheter within the previous 30 days.

          -  The Subject has sepsis, ventriculitis, meningitis, a skin infection/inflammation at or
             near the implantation site, an ear infection on either side, or a severe respiratory
             tract infection that, in the opinion of the Investigator, would most likely compromise
             the effectiveness of the EVD system.

          -  The Subject is known to have received systemic antibiotic therapy within a 14-day
             period preceding screening for inclusion in this trial.

          -  The Subject has an uncontrolled coagulopathy or any other known bleeding diathesis.

          -  The Subject is otherwise determined by the Investigator to be medically unsuitable for
             participation in this trial.

          -  The Subject is a prisoner.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J. Thomas Megerian, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Unaffilliated</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tiantan Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Xuan Wu Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prince of Wales Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Mary Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oslo</city>
        <zip>NO-0027</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Neuroscience Institute</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Singapore General Hospital</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bristol</city>
        <zip>BS 16 1LE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Leeds</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Salford</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>China</country>
    <country>France</country>
    <country>Hong Kong</country>
    <country>Norway</country>
    <country>Singapore</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Codman in house testing reports, TR2213 and PVER99-133 Addendum</citation>
  </reference>
  <reference>
    <citation>Bayston R. Hydrocephalus Shunt Infections. Chapman and Hall Medical, London, 1989, p. 23.</citation>
  </reference>
  <reference>
    <citation>Bayston R, Grove N, Siegel J, Lawellin D, Barsham S. Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry. 1989 May;52(5):605-9.</citation>
    <PMID>2732730</PMID>
  </reference>
  <reference>
    <citation>Bayston R, Lambert E. Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J Neurosurg. 1997 Aug;87(2):247-51.</citation>
    <PMID>9254088</PMID>
  </reference>
  <reference>
    <citation>Govender ST, Nathoo N, van Dellen JR. Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg. 2003 Nov;99(5):831-9.</citation>
    <PMID>14609161</PMID>
  </reference>
  <reference>
    <citation>Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES Jr. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery. 2002 Jul;51(1):170-81; discussion 181-2. Review.</citation>
    <PMID>12182415</PMID>
  </reference>
  <reference>
    <citation>Schierholz J, Jansen B, Jaenicke L, Pulverer G. In-vitro efficacy of an antibiotic releasing silicone ventricle catheter to prevent shunt infection. Biomaterials. 1994 Oct;15(12):996-1000.</citation>
    <PMID>7841297</PMID>
  </reference>
  <reference>
    <citation>Zabramski JM, Whiting D, Darouiche RO, Horner TG, Olson J, Robertson C, Hamilton AJ. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg. 2003 Apr;98(4):725-30.</citation>
    <PMID>12691395</PMID>
  </reference>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <results_first_submitted>March 2, 2012</results_first_submitted>
  <results_first_submitted_qc>October 11, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 5, 2013</results_first_posted>
  <last_update_submitted>October 11, 2013</last_update_submitted>
  <last_update_submitted_qc>October 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ventriculostomy</keyword>
  <keyword>EVD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Cerebral Hemorrhage</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Bactiseal EVD</title>
          <description>Subjects treated with Bactiseal EVD catheter</description>
        </group>
        <group group_id="P2">
          <title>Conventional EVD Catheter</title>
          <description>Subjects treated with Standard EVD catheter</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="214"/>
                <participants group_id="P2" count="220"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Safety Population</title>
              <participants_list>
                <participants group_id="P1" count="214"/>
                <participants group_id="P2" count="220"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Modified Intent to Treat</title>
              <participants_list>
                <participants group_id="P1" count="209"/>
                <participants group_id="P2" count="210"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Evaluable</title>
              <participants_list>
                <participants group_id="P1" count="176"/>
                <participants group_id="P2" count="181"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Per Protocol</title>
              <participants_list>
                <participants group_id="P1" count="126"/>
                <participants group_id="P2" count="134"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="126"/>
                <participants group_id="P2" count="134"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="88"/>
                <participants group_id="P2" count="86"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Bactiseal EVD</title>
        </group>
        <group group_id="B2">
          <title>Standard EVD</title>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="214"/>
            <count group_id="B2" value="220"/>
            <count group_id="B3" value="434"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51.7" spread="16.2"/>
                    <measurement group_id="B2" value="54.4" spread="14.7"/>
                    <measurement group_id="B3" value="53.05" spread="15.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="110"/>
                    <measurement group_id="B2" value="110"/>
                    <measurement group_id="B3" value="220"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="104"/>
                    <measurement group_id="B2" value="110"/>
                    <measurement group_id="B3" value="214"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>France</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hong Kong</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Singapore</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Norway</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>China</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Infections</title>
        <description>The number of infections for the Codman Bactiseal EVD Catheter and the number of infections for a Standard EVD Catheter (ventriculostomy-related infections).</description>
        <time_frame>Duration of implanted EVD system to 2 week post implant</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bactiseal EVD Catheter</title>
            <description>Patients treated with Codman Bactiseal EVD Catheter</description>
          </group>
          <group group_id="O2">
            <title>Standard EVD Cathter</title>
            <description>Patients treated with Standard EVD Catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Infections</title>
          <description>The number of infections for the Codman Bactiseal EVD Catheter and the number of infections for a Standard EVD Catheter (ventriculostomy-related infections).</description>
          <units>Infections</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="210"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Modified intent to Treat</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Evaluable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Per Protocol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Days to Proven Infection</title>
        <description>Number of days to proven infection.</description>
        <time_frame>Implantation of EVD System to explant of EVD catheter, an average of ten days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bactiseal EVD Catheter</title>
            <description>Patients treated with Codman Bactiseal EVD Catheter</description>
          </group>
          <group group_id="O2">
            <title>Standard EVD Catheter</title>
            <description>Patients treated with standard EVD catheter.</description>
          </group>
        </group_list>
        <measure>
          <title>Days to Proven Infection</title>
          <description>Number of days to proven infection.</description>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="214"/>
                <count group_id="O2" value="220"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Modified Intent to Treat</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.5" spread="3.3"/>
                    <measurement group_id="O2" value="10" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Evaluable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.5" spread="3.3"/>
                    <measurement group_id="O2" value="10" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Per protocol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14" spread="1"/>
                    <measurement group_id="O2" value="10" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Class of Bacterial Agent Causing Proven Infection</title>
        <description>Type of bacterial agent related to proven infection in Bactiseal EVD and Standard EVD</description>
        <time_frame>Implantation of subject to post implant</time_frame>
        <population>All subjects included in the MITT, Evaluable and Per-Protocol population.</population>
        <group_list>
          <group group_id="O1">
            <title>Bactiseal - EVD Catheter</title>
            <description>Patients treated with Bactiseal EVD catheter</description>
          </group>
          <group group_id="O2">
            <title>Standard EVD Catheter</title>
            <description>Patient treated with Standard EVD Catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Class of Bacterial Agent Causing Proven Infection</title>
          <description>Type of bacterial agent related to proven infection in Bactiseal EVD and Standard EVD</description>
          <population>All subjects included in the MITT, Evaluable and Per-Protocol population.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Bacilli</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gamma Proteobacteria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intraluminal Colonization on Catheters</title>
        <description>Number of catheters with Bacterial colonization verified using fluorescence.</description>
        <time_frame>Implant of subjects to post implant</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bactiseal EVD Catheter</title>
            <description>Patients implanted with Bactiseal EVD Catheter</description>
          </group>
          <group group_id="O2">
            <title>Standard EVD Catheter</title>
            <description>Patients implanted with Standard EVD Catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Intraluminal Colonization on Catheters</title>
          <description>Number of catheters with Bacterial colonization verified using fluorescence.</description>
          <units>catheters</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="210"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Device Related Adverse Events</title>
        <description>Number of Device Related Adverse Events</description>
        <time_frame>Implanted subjects to time of explant</time_frame>
        <population>There were 8 device-related events, 7 of which were in subjects that received a standard catheter. None of the 8 subjects were proven infections.</population>
        <group_list>
          <group group_id="O1">
            <title>Bactiseal EVD Catheter</title>
            <description>Patients implanted with Bactiseal EVD Catheter</description>
          </group>
          <group group_id="O2">
            <title>Standard EVD Catheter</title>
            <description>Patients implanted with standard EVD catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Device Related Adverse Events</title>
          <description>Number of Device Related Adverse Events</description>
          <population>There were 8 device-related events, 7 of which were in subjects that received a standard catheter. None of the 8 subjects were proven infections.</population>
          <units>events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="214"/>
                <count group_id="O2" value="220"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Modifeid Intent to Treat</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Evaluable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Per protocol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Safety</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Days With Indwelling Catheter</title>
        <description>Days catheter was implanted in subjects</description>
        <time_frame>Implant of subjects to day of explant</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bactiseal EVD Catheter</title>
            <description>Patients implanted with Bactiseal EVD Catheter</description>
          </group>
          <group group_id="O2">
            <title>Standard EVD Catheter</title>
            <description>Patients implanted with Standard EVD Catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Days With Indwelling Catheter</title>
          <description>Days catheter was implanted in subjects</description>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="192"/>
                <count group_id="O2" value="199"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Modified Intent to Treat</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.7" spread="5.7"/>
                    <measurement group_id="O2" value="8.9" spread="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Evaluable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.3" spread="5.5"/>
                    <measurement group_id="O2" value="9.7" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Per Protocol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.8" spread="5.7"/>
                    <measurement group_id="O2" value="10.4" spread="5.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Average Subject Age</title>
        <description>The average subject age</description>
        <time_frame>Implant to subject</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bactiseal EVD Catheter</title>
            <description>Subjects implanted with Bactiseal EVD Catheter</description>
          </group>
          <group group_id="O2">
            <title>Standard EVD Catheter</title>
            <description>Subjects implanted with standard EVD catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Average Subject Age</title>
          <description>The average subject age</description>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="210"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Modified Intent to Treat</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.9" spread="16.1"/>
                    <measurement group_id="O2" value="54.4" spread="14.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Evaluable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.9" spread="16.1"/>
                    <measurement group_id="O2" value="54.5" spread="14.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Per protocol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.4" spread="15.8"/>
                    <measurement group_id="O2" value="54.2" spread="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diagnosis Requiring EVD Implantation</title>
        <description>Primary diagnosis for implantation of EVD system</description>
        <time_frame>Implantation of EVD system</time_frame>
        <population>Analysis consisted of combining both Arm/Group (Bactiseal and Standard)</population>
        <group_list>
          <group group_id="O1">
            <title>Bactiseal EVD Catheter and Standard EVD Cathter</title>
            <description>Patients implanted with Bactiseal EVD Catheter or Standard EVD Catheter.</description>
          </group>
        </group_list>
        <measure>
          <title>Diagnosis Requiring EVD Implantation</title>
          <description>Primary diagnosis for implantation of EVD system</description>
          <population>Analysis consisted of combining both Arm/Group (Bactiseal and Standard)</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="419"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Edema - Modified Intent to Treat</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Edema - Evaluable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Edema - Per Protocol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hemorrhage - Modified Intent to Treat</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="335"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hemorrhage - Evaluable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="282"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hemorrhage - Per protocol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="197"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydrocephalus - Modified Intent to Treat</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydrocephalus - Evaluable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydrocephalus - Per Protocol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Non-infectious Catheter Failure in the MITT Population</title>
        <description>Reasons for non-infectious catheter malfunctions in the Modified intent to treat population.</description>
        <time_frame>Implant of subject to explant</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bactiseal EVD Catheter</title>
            <description>Subjects treated with Bactiseal EVD Catheter</description>
          </group>
          <group group_id="O2">
            <title>Standard EVD Catheter</title>
            <description>Subjects treated with standard EVD catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Non-infectious Catheter Failure in the MITT Population</title>
          <description>Reasons for non-infectious catheter malfunctions in the Modified intent to treat population.</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="176"/>
                <count group_id="O2" value="181"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Occlusion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Migration</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Misplacement</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time Point of Introduction of Systemic Antibiotic Therapy</title>
        <description>Time points of then patients received systemic antibiotic therapy</description>
        <time_frame>Within 48 hours of implant of subjects to explant</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bactiseal EVD Catheter</title>
            <description>Subjects implanted with Bactiseal EVD Catheter</description>
          </group>
          <group group_id="O2">
            <title>Standrad EVD Catheter</title>
            <description>Subjects implanted with standard EVD catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Time Point of Introduction of Systemic Antibiotic Therapy</title>
          <description>Time points of then patients received systemic antibiotic therapy</description>
          <units>Paticipants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="210"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Before implant, but within 48 hours (MITT)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="146"/>
                    <measurement group_id="O2" value="149"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Catheter Implanted (MITT)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="167"/>
                    <measurement group_id="O2" value="175"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before implant, but within 48 hours (Evaluable)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="118"/>
                    <measurement group_id="O2" value="124"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Catheter Implanted (Evaluable)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="150"/>
                    <measurement group_id="O2" value="159"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before implant, but within 48 hours (Per protocol)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81"/>
                    <measurement group_id="O2" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Catheter implanted (Per Protocol)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="108"/>
                    <measurement group_id="O2" value="121"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospital Locations for EVD Catheter Placement</title>
        <description>Number of subjects in each analysis population where the EVD catheter placement occurred; either in the Intensive Care Unit (ICU)or the Operating Room (OR).</description>
        <time_frame>Implantation of subject</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bactiseal EVD Catheter</title>
            <description>Subjects implanted with the Bactiseal EVD Catheter</description>
          </group>
          <group group_id="O2">
            <title>Standard EVD Catheter</title>
            <description>Subjects implanted with a standard EVD catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Locations for EVD Catheter Placement</title>
          <description>Number of subjects in each analysis population where the EVD catheter placement occurred; either in the Intensive Care Unit (ICU)or the Operating Room (OR).</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="214"/>
                <count group_id="O2" value="220"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>ICU (MITT)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                    <measurement group_id="O2" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>OR (MITT)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="159"/>
                    <measurement group_id="O2" value="153"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ICU (Evaluable)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>OR (Evaluable)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="136"/>
                    <measurement group_id="O2" value="132"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ICU (Per Protocol)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>OR (Per Protocol)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="103"/>
                    <measurement group_id="O2" value="106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Catheter Tunneling Into the Brain</title>
        <description>Length of tunneling of EVD catheter in the brain for each analysis population.</description>
        <time_frame>Implant of subject</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bactiseal EVD Catheter</title>
            <description>Subjects implanted with Bactiseal EVD Catheter</description>
          </group>
          <group group_id="O2">
            <title>Standard EVD Catheter</title>
            <description>Subjects implanted with a standard EVD catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Catheter Tunneling Into the Brain</title>
          <description>Length of tunneling of EVD catheter in the brain for each analysis population.</description>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="202"/>
                <count group_id="O2" value="205"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>MITT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.2" spread="2.2"/>
                    <measurement group_id="O2" value="5.8" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Evaluable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.2" spread="2.1"/>
                    <measurement group_id="O2" value="5.8" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Per Protocol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0" spread="1.9"/>
                    <measurement group_id="O2" value="5.7" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Catheter Insertion Attempts</title>
        <description>Number of insertions needed to place catheter</description>
        <time_frame>Implantation of subject</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bactiseal EVD</title>
            <description>Subjects implanted with Bactiseal EVD catheters.</description>
          </group>
          <group group_id="O2">
            <title>Standard EVD</title>
            <description>Subjects implanted with Standard EVD catheters.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Catheter Insertion Attempts</title>
          <description>Number of insertions needed to place catheter</description>
          <units>insertions</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="206"/>
                <count group_id="O2" value="208"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 Insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="177"/>
                    <measurement group_id="O2" value="178"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 insertions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 instertions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 instertions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 insertions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Standard EVD</title>
          <description>Subjects with standard EVD</description>
        </group>
        <group group_id="E2">
          <title>Bactiseal EVD</title>
          <description>Subjects with Bactiseal EVD</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="220"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="214"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Right intracerebral hemorhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="214"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Sepsis secondary to pneumonia with complicating head injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Respiratory culture positive for staphylocccus</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Respiratory culture positive for enterobateraerogenes</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="220"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Respiratory culture positive for haemophilus influenzae</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Respiratory culture positive for staphylocccus aureus-oxacillan resistant (orsa)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Throat culture positive for enterobacter aerogenes</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Nares culture positive for oxacillan resistant staphylocccus aureus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>CSF positive for coccidiodes immitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Respiratory culture positive for escherichia coli</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>CSF culture positive for coagulase negative staphylococcus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Epidural hematoma at ventriculostomy site</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>CSF infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="220"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>CSF infection with secondary hydrocephalus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Aseptic Inflammation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Meningitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Blood Culture Positive for Coagulase Negative Staphylococcus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="214"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Brain Death</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="220"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Ventriculitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Vasovagal Shock at EVD Explant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="214"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="214"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="220"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="214"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Stomach Ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="214"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Blood positive for streptococcus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>CNS Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="220"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Coagulase negative staphylococcus in CSF</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Confirmed dipthroid infection in CSF</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>CSF culture positive for coagulase negative staphylococcus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>CSF Positive for propionibacterium</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="220"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>CSF infection - entermococcus faecacil acinetobacter banmanii</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>CSF Infection - pseudomonas</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Catheter tip - cultutre positive for coagulase negative staphylococcus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Meningitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Sputum culture positive with gram positive cocci &amp; gram negative diplococci</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Sputum positive for gram negative &amp; gram positive rods</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Sputum positive for staphylococcus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Urine positive for escherichia coli</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Sputum Positive for Staphylococcus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="220"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="214"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Increrased intra-cranial pressure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="214"/>
              </event>
              <event>
                <sub_title>Vasovagal Shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="214"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Trubid CSF</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="214"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Catheter occlusion due to hemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="214"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>J. Thomas Megerian, MD</name_or_title>
      <organization>Codman &amp; Shurtleff, Inc</organization>
      <phone>508.880.8274</phone>
      <email>jmegeri1@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

